Related Experiment Video
Updated: Jan 17, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
Physiologically based toxicokinetic models in aggregate exposure: A review
L Lamon1, A Paini1, M Siccardi1
1ESQlabs GmbH, Am Sportplatz 7, Saterland 26683, Germany.
Physiologically Based Kinetic (PBK) models are crucial for aggregate exposure (AE) assessment, integrating human biomonitoring (HBM) data for reliable chemical risk assessment. This review highlights their broad application and future potential in advancing human health protection.
Area of Science:
- Environmental Health Sciences
- Toxicology
- Computational Biology
Background:
- Aggregate exposure (AE) assessment is vital for chemical risk assessment (CRA).
- Physiologically Based Kinetic (PBK) models offer a robust framework for AE evaluation.
- Existing literature on PBK model applications in AE assessment requires synthesis.
Purpose of the Study:
- To conduct a scoping review of PBK model applications in AE assessment.
- To identify chemical classes and exposure scenarios where PBK models are utilized.
- To explore the integration of human biomonitoring (HBM) data with PBK models for enhanced reliability.
Main Methods:
- Systematic literature search across 1119 publications.
- Identification and selection of 40 relevant articles for review.
- Analysis of PBK model applications, chemical classes, exposure scenarios, and data sources.
Main Results:
- PBK models are widely applied in AE assessment, particularly for volatile organic compounds and plant protection products.
- Human populations are the primary focus, with HBM data frequently used to improve model accuracy.
- Studies support chemical risk assessment (CRA) and explore forward/reverse dosimetry for refined AE evaluations.
Conclusions:
- PBK models, especially when combined with HBM data, are essential for reliable AE and CRA.
- A broad interpretation of AE exists, necessitating standardized definitions.
- This review provides a foundation for future research in PBK modeling for Next-Generation Risk Assessment (NGRA).
More Related Videos
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
08:59An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Related Concept Videos
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Model Approaches for Pharmacokinetic Data: Physiological Models
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Overview of Compartment Models